Skip to main content
SpringerLink
Log in

Headache: Ethics, Outcome Variables and Clinical Studies

  • Chapter
Clinical Trials in Neurology

  • 262 Accesses

Abstract

There have been an enormous number of clinical trials in headache in recent years, largely as a result of the introduction of the International Headache Society diagnostic criteria for headache [1], and the development of 5-hydroxytryptamine (5HT) agonists for acute treatment, originally by one company. Interested readers are referred to an authoritative multi-author text that has recently been published [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7).

    Google Scholar 

  2. Olesen J, Tfelt-Hansen P (eds). Headache treatment: trial methodology and new drugs. New York: Lippincott-Raven, 1997.

    Google Scholar 

  3. Peatfield R. Headache. Berlin: Springer, 1986.

    Book  Google Scholar 

  4. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford: ISIS Medical Media, 1998.

    Google Scholar 

  5. IHS Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. Cephalalgia 1991; 11: 1–12.

    Google Scholar 

  6. Forsythe WI, Gillies D, Sills MA. Propranolol (“Inderal”) in the treatment of childhood migraine. Dev Med Child Neurol 1984; 26: 737–741.

    Article  PubMed  CAS  Google Scholar 

  7. Lipton RB, Stewart WF, von Korff M. Burden of migraine: societal costs and therapeutic opportunities. Neurology 1997; 48 (Suppl 3): 4–9.

    Article  Google Scholar 

  8. Ad Hoc Committee. Classification of headache. JAMA 1962; 179: 717–718.

    Google Scholar 

  9. Vahlquist B. Migraine in children. Int Arch Allergy 1955; 7: 348–355.

    Article  PubMed  CAS  Google Scholar 

  10. Metsähonkala L, Sillanpää M. Migraine in children: an evaluation of the IHS criteria. Cephalalgia 1994; 14: 285–290.

    Article  PubMed  Google Scholar 

  11. Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol 1991; 31: 295–299.

    Article  PubMed  CAS  Google Scholar 

  12. Goadsby PJ. A triptan too far? J Neurol Neurosurg Psychiatry 1998; 64: 143–147.

    Article  PubMed  CAS  Google Scholar 

  13. Olesen J, Tfelt-Hansen P. Methodology of clinical trials in migraine. In: Capildeo R, Orgogozo JM, editors. Methods in clinical trials in neurology: vascular and degenerative brain disease. London: Stockton Press, 1988: 85–109.

    Google Scholar 

  14. Tfelt-Hansen P, Olesen J. Methodological aspects of drug trials in migraine. Neuroepidemiology 1985; 4: 204–226.

    Article  PubMed  CAS  Google Scholar 

  15. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995; 52: 281–286.

    Article  PubMed  CAS  Google Scholar 

  16. Schmuck K, Ullmer C, Kalkman HO, Probst A, Lübbert H. Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci 1996; 8: 959–967.

    Article  PubMed  CAS  Google Scholar 

  17. Lewis JA. Migraine trials: crossover or parallel group? Neuro-epidemiology 1987; 6: 198–208.

    CAS  Google Scholar 

  18. Jones B, Lewis JA. Cross-over trials versus parallel-group trials. In: Olesen J, Tfelt-Hansen P, editors. Headache treatment: trial methodology and new drugs. Philadelphia: Lippincott-Raven, 1997: 35–43.

    Google Scholar 

  19. Pfaffenrath V, Diener H-C, Isler H, Meyer C, Scholz E, Taneri Z, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 1994; 14: 149–155.

    Article  PubMed  CAS  Google Scholar 

  20. Steiner TJ, Catarci T, Hering R,Whitmarsh T, Courturier EGM. If migraine prophylaxis does not work, think about compliance. Cephalalgia 1994; 14: 463–464.

    Article  PubMed  CAS  Google Scholar 

  21. Fogan L. Treatment of cluster headache: a double-blind comparison of oxygen vs air inhalation. Arch Neurol 1985; 42: 362–363.

    Article  PubMed  CAS  Google Scholar 

  22. Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991; 325: 322–326.

    Google Scholar 

  23. Ekbom K. Treatment of cluster headache: clinical trials, design and results. Cephalalgia 1995;Suppl 15: 33–36.

    Google Scholar 

  24. Krabbe AA. Cluster headache: a review. Acta Neurol Scand 1986; 74: 1–9.

    Article  PubMed  CAS  Google Scholar 

  25. International Headache Society Committee on Clinical Trials in Cluster Headache. Guidelines for controlled trials of drugs in cluster headache. Cephalalgia 1995; 15: 452–462.

    Google Scholar 

  26. Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30: 411–417.

    Article  PubMed  CAS  Google Scholar 

  27. de Carolis P, de Capoa D, Agati R, Baldrati A, Sacquegna T. Episodic cluster headache: short and long term results of prophylactic treatment. Headache 1988; 28: 475–476.

    Article  PubMed  Google Scholar 

  28. International Headache Society Committee on Clinical Trials. Guidelines for trials of drug treatments in tension-type headache. Cephalalgia 1995; 15: 165–279.

    Google Scholar 

  29. Göbel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V, et al. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994; 59: 241–249.

    Article  PubMed  Google Scholar 

  30. Mathew NT. Tension-type headache, cluster headache, and miscellaneous headaches: acute pharmacotherapy. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993: 531–536.

    Google Scholar 

  31. Schachtel BP, Thoden WR. Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988; 28: 471–474.

    Article  PubMed  CAS  Google Scholar 

  32. Couch JR, Micieli G. Prophylactic pharmacotherapy. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993.

    Google Scholar 

  33. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996; 61: 285–290.

    Article  PubMed  CAS  Google Scholar 

  34. Meyler WJ. Side effects of ergotamine. Cephalalgia 1996; 16: 5–10.

    Article  PubMed  CAS  Google Scholar 

  35. Pfaffenrath V, Niederberger U. What kind of drugs are taken by patients with primary headaches? In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer, 1988: 44–62.

    Chapter  Google Scholar 

  36. Walker J, Parisi S, Olive D. Analgesic rebound headache: experience in a community hospital. South Med J 1993; 86: 1202–1205.

    Article  PubMed  CAS  Google Scholar 

  37. Tzourio C, Tehindrazanarivelo A, Iglésias S, Alpérovitch A, Chedru F, d’Anglejan-Chatillon J, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995; 310: 830–834.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Peatfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neuromuscular Unit, West London Neurosciences Centre, 1st Floor Pilot Wing, Charing Cross Hospital, Fulham Palace Road, W6 8RF, London, UK

    Roberto J. Guiloff MD, FRCP (Consultant Neurologist) (Consultant Neurologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag London

About this chapter

Cite this chapter

Peatfield, R. (2001). Headache: Ethics, Outcome Variables and Clinical Studies. In: Guiloff, R.J. (eds) Clinical Trials in Neurology. Springer, London. https://doi.org/10.1007/978-1-4471-3787-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3787-0_22

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-856-0

  • Online ISBN: 978-1-4471-3787-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation